Bleakley Financial Group’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Buy
16,277
+1,705
+12% +$137K 0.02% 576
2026
Q1
$1.22M Sell
14,572
-4,966
-25% -$374K 0.02% 486
2025
Q4
$1.31M Buy
19,538
+2,399
+14% +$155K 0.02% 423
2025
Q3
$1.16M Buy
17,139
+1,504
+10% +$109K 0.03% 383
2025
Q2
$1.17M Buy
15,635
+2,754
+21% +$183K 0.03% 370
2025
Q1
$811K Buy
12,881
+205
+2% +$12.7K 0.03% 370
2024
Q4
$722K Buy
12,676
+597
+5% +$35.3K 0.02% 505
2024
Q3
$710K Sell
12,079
-426
-3% -$23.3K 0.02% 494
2024
Q2
$675K Sell
12,505
-734
-6% -$40.4K 0.02% 514
2024
Q1
$764K Buy
13,239
+1,237
+10% +$63.9K 0.02% 493
2023
Q4
$575K Sell
12,002
-1,641
-12% -$78.2K 0.02% 547
2023
Q3
$698K Sell
13,643
-2,276
-14% -$121K 0.02% 467
2023
Q2
$912K Sell
15,919
-890
-5% -$51.9K 0.03% 424
2023
Q1
$1.01M Sell
16,809
-446
-3% -$27.2K 0.03% 383
2022
Q4
$1.01M Buy
+17,255
New +$1.09M 0.04% 370

Other funds holding CTVA

Bleakley Financial Group's CTVA Position: Q2 2026 in Review

Bleakley Financial Group increased its Corteva (CTVA) stake by 12% in Q2 2026, buying an estimated $137K and bringing the position to 16,277 shares worth $1.38M. The position accounts for 0.02% of the portfolio, ranked #576.

Bleakley Financial Group first reported a position in CTVA in Q4 2022 and has held it in 15 quarters since. 1,491 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Bleakley Financial Group held 16,277 shares of Corteva worth $1.38M as of Q2 2026.
  • Bleakley Financial Group bought 1,705 Corteva shares in Q2 2026, an estimated $137K.
  • Corteva made up 0.02% of Bleakley Financial Group's portfolio in Q2 2026, its #576 holding.
  • Bleakley Financial Group first reported a position in Corteva in Q4 2022 and has held it in 15 quarters since.
  • 1,491 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.